Learning Objectives:

Cahill:

1.  Review the biology of follicular lymphoma (FL)

2.  Highlight the current treatment paradigm

3.  Discuss a phase ½ clinical trial of obinutuzumab, oral azcitidine (CC-486), and venetoclax in FL

 

Paydary:

  1. To provide an overview on the current standard of care in the management of advanced upper GI cancers
  2. To discuss the findings of previous phase 1 trials in the treatment of advanced, high risk upper GI cancers

3.    To discuss the design and initial findings of our institutional phase 1 I-FLOAT study

Session date: 
10/14/2021 - 12:00pm to 1:00pm CDT
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Kirk Cahill, MD and Koosha Paydary, MD